Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
about
Porcine circovirus: a historical perspectivePorcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs.Development and application of an ELISA for the detection of porcine deltacoronavirus IgG antibodies.Antigenic Determinants of Possible Vaccine Escape by Porcine Circovirus Subtype 2b Viruses.Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2.Evaluation of natural porcine circovirus type 2 (PCV2) subclinical infection and seroconversion dynamics in piglets vaccinated at different ages.MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins.Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: A large scale epidemiological study.Porcine epidemic diarrhea virus virus-like particles produced in insect cells induce specific immune responses in mice.Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United StatesMarburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in miceComplete genome sequence of a novel field strain of rearranged porcine circovirus type 2 in southern China.Granulomatous Necrotizing Myositis in Swine Affected by Porcine Circovirus Disease.
P2860
Q28308000-376FBC6B-AB57-403F-B484-13FC407EAC45Q30234530-53D53DF4-4A22-470D-9E6E-E5B5A8197E55Q34366429-5ACB2877-A96F-4D0E-ACEA-E5B056F4764FQ35447489-BF3BF9CB-2ECA-499B-B321-D36E9887AB94Q35997585-843F5962-D850-4D84-8A85-835EFDCCE957Q36414373-C215CDBC-98B3-4F06-9C2B-B60D8353B1C5Q37470430-785097B8-269A-4F96-9D6F-2FECE41F7295Q37706472-C841276E-CEB0-4150-80F1-0F24E16E41EDQ38903870-F329F947-8F3B-4200-A1E8-3917202F932BQ39500288-E2EFD9B6-0368-4AA5-90C7-F18256F15A22Q40267316-6BD36114-E255-4C5A-AE11-F80887D7EA57Q41574498-9C3096A1-4697-415F-823C-987A8FD9E9EDQ42628113-F5651370-769A-4D5A-9A6A-AF2145C4E1A7Q42667385-CA99AFE9-C131-4BBA-88EB-03371B2D21D5Q50098300-A8CB5831-CCF1-4FA4-8D93-C88AD7201ED7
P2860
Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prevalence and phylogenetic an ...... ination programmes in the USA.
@en
Prevalence and phylogenetic an ...... ination programmes in the USA.
@nl
type
label
Prevalence and phylogenetic an ...... ination programmes in the USA.
@en
Prevalence and phylogenetic an ...... ination programmes in the USA.
@nl
prefLabel
Prevalence and phylogenetic an ...... ination programmes in the USA.
@en
Prevalence and phylogenetic an ...... ination programmes in the USA.
@nl
P2093
P356
P1476
Prevalence and phylogenetic an ...... ination programmes in the USA.
@en
P2093
Hui-Gang Shen
Patrick G Halbur
Tanja Opriessnig
P304
P356
10.1099/VIR.0.039552-0
P407
P577
2012-03-07T00:00:00Z